Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Effectiveness of alternative dose fingolimod for multiple sclerosis.

Longbrake EE, Kantor D, Pawate S, Bradshaw MJ, von Geldern G, Chahin S, Cross AH, Parks BJ, Rice M, Khoury SJ, Yamout B, Zeineddine M, Russell-Giller S, Caminero-Rodriguez A, Edwards K, Lathi E, VanderKodde D, Meador W, Berkovich R, Ge L, Bacon TE, Kister I.

Neurol Clin Pract. 2018 Apr;8(2):102-107. doi: 10.1212/CPJ.0000000000000434.

PMID:
29708225
2.

Brain pathology of a patient 7years after autologous hematopoietic stem cell transplantation for multiple sclerosis.

Wundes A, Bowen JD, Kraft GH, Maravilla KR, McLaughlin B, von Geldern G, Georges G, Nash RA, Lu JQ.

J Neurol Sci. 2017 Feb 15;373:339-341. doi: 10.1016/j.jns.2017.01.016. Epub 2017 Jan 7.

PMID:
28131217
3.

Dietary Interventions in Multiple Sclerosis: Development and Pilot-Testing of an Evidence Based Patient Education Program.

Riemann-Lorenz K, Eilers M, von Geldern G, Schulz KH, Köpke S, Heesen C.

PLoS One. 2016 Oct 20;11(10):e0165246. doi: 10.1371/journal.pone.0165246. eCollection 2016.

4.

Accelerating international MS care through videoconference-based education and case consultation.

Alschuler KN, Wundes A, Dietrich DW, Boskovski B, Kuzmanovski I, Alexander KS, von Geldern G, Stobbe GA.

Neurology. 2016 Jul 5;87(1):e8-e10. doi: 10.1212/WNL.0000000000002812. No abstract available.

5.

Human endogenous retrovirus-K contributes to motor neuron disease.

Li W, Lee MH, Henderson L, Tyagi R, Bachani M, Steiner J, Campanac E, Hoffman DA, von Geldern G, Johnson K, Maric D, Morris HD, Lentz M, Pak K, Mammen A, Ostrow L, Rothstein J, Nath A.

Sci Transl Med. 2015 Sep 30;7(307):307ra153. doi: 10.1126/scitranslmed.aac8201.

PMID:
26424568
6.

Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF.

Warnke C, Stettner M, Lehmensiek V, Dehmel T, Mausberg AK, von Geldern G, Gold R, Kümpfel T, Hohlfeld R, Mäurer M, Stangel M, Straeten V, Limmroth V, Weber T, Kleinschnitz C, Wattjes MP, Svenningsson A, Olsson T, Hartung HP, Hermsen D, Tumani H, Adams O, Kieseier BC.

Mult Scler. 2015 Jul;21(8):1036-44. doi: 10.1177/1352458514556296. Epub 2014 Nov 12.

PMID:
25392339
7.

Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project.

Carson KR, Newsome SD, Kim EJ, Wagner-Johnston ND, von Geldern G, Moskowitz CH, Moskowitz AJ, Rook AH, Jalan P, Loren AW, Landsburg D, Coyne T, Tsai D, Raisch DW, Norris LB, Bookstaver PB, Sartor O, Bennett CL.

Cancer. 2014 Aug 15;120(16):2464-71. doi: 10.1002/cncr.28712. Epub 2014 Apr 25.

8.

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.

Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, Hermsen D, Kleinschnitz C, Hartung HP, Wattjes MP, Svenningson A, Major E, Olsson T, Kieseier BC, Adams O.

Ann Neurol. 2014 Dec;76(6):792-801. doi: 10.1002/ana.24153. Epub 2014 May 8.

9.

Derivation of neural stem cells from human adult peripheral CD34+ cells for an autologous model of neuroinflammation.

Wang T, Choi E, Monaco MC, Campanac E, Medynets M, Do T, Rao P, Johnson KR, Elkahloun AG, Von Geldern G, Johnson T, Subramaniam S, Hoffman DA, Major E, Nath A.

PLoS One. 2013 Nov 26;8(11):e81720. doi: 10.1371/journal.pone.0081720. eCollection 2013. Erratum in: PLoS One. 2014;9(3):e91277. Hoffman, Dax [corrected to Hoffman, Dax A].

10.

PML-IRIS in a patient treated with brentuximab.

von Geldern G, Pardo CA, Calabresi PA, Newsome SD.

Neurology. 2012 Nov 13;79(20):2075-7. doi: 10.1212/WNL.0b013e3182749f17. Epub 2012 Oct 31.

11.

The influence of nutritional factors on the prognosis of multiple sclerosis.

von Geldern G, Mowry EM.

Nat Rev Neurol. 2012 Dec;8(12):678-89. doi: 10.1038/nrneurol.2012.194. Epub 2012 Oct 2. Review.

PMID:
23026980
12.

HIV-associated opportunistic infections of the CNS.

Tan IL, Smith BR, von Geldern G, Mateen FJ, McArthur JC.

Lancet Neurol. 2012 Jul;11(7):605-17. doi: 10.1016/S1474-4422(12)70098-4. Review.

PMID:
22710754
13.

Immune mediated diseases and immune modulation in the neurocritical care unit.

von Geldern G, McPharlin T, Becker K.

Neurotherapeutics. 2012 Jan;9(1):99-123. doi: 10.1007/s13311-011-0096-3. Review.

14.

Enhancement of chemokine expression by interferon beta therapy in patients with multiple sclerosis.

Cepok S, Schreiber H, Hoffmann S, Zhou D, Neuhaus O, von Geldern G, Hochgesand S, Nessler S, Rothhammer V, Lang M, Hartung HP, Hemmer B.

Arch Neurol. 2009 Oct;66(10):1216-23. doi: 10.1001/archneurol.2009.138. Epub 2009 Aug 10.

PMID:
19667211
15.

Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy.

Stüve O, Cravens PD, Frohman EM, Phillips JT, Remington GM, von Geldern G, Cepok S, Singh MP, Tervaert JW, De Baets M, MacManus D, Miller DH, Radü EW, Cameron EM, Monson NL, Zhang S, Kim R, Hemmer B, Racke MK.

Neurology. 2009 Feb 3;72(5):396-401. doi: 10.1212/01.wnl.0000327341.89587.76. Epub 2008 Nov 5.

16.

Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection.

Cepok S, von Geldern G, Nolting T, Grummel V, Srivastava R, Zhou D, Hartung HP, Adams O, Arendt G, Hemmer B.

Ann Neurol. 2007 Nov;62(5):458-67.

PMID:
17703460
17.

CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals.

von Geldern G, Cepok S, Nolting T, Du Y, Grummel V, Adams O, Hartung HP, Arendt G, Hemmer B.

AIDS. 2007 Jan 11;21(2):250-3.

PMID:
17197822
18.

Accumulation of class switched IgD-IgM- memory B cells in the cerebrospinal fluid during neuroinflammation.

Cepok S, von Geldern G, Grummel V, Hochgesand S, Celik H, Hartung H, Hemmer B.

J Neuroimmunol. 2006 Nov;180(1-2):33-9. Epub 2006 Sep 6.

PMID:
16952404
19.

A 32-year-old man with relapsing-progressive brainstem symptoms.

Lehmann HC, Hengge UR, Alswede L, Saleh A, von Geldern G, Hartung HP, Ruzicka T, Hemmer B.

Lancet Neurol. 2006 Jan;5(1):97-102. No abstract available.

PMID:
16361027

Supplemental Content

Loading ...
Support Center